Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARADIGM CORP | 276,000 | reported | 22 Mar 2018 | tx 19+2,008,813 |
| SUPERNUS PHARMACEUTICALS, INC. | 87,943 | reported | 23 Feb 2024 | tx 44+241,951−69,732 |
| CIMA LABS INC | 0 | reported | 12 Aug 2004 | tx 23+186,309−557,738 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 0.00 USD | |
| 23 Feb 2024 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 8,252 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 6,293 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 0.00 USD | deriv |
| 22 Feb 2023 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,882 | 0.00 USD | |
| 22 Feb 2023 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 3,882 | 0.00 USD | deriv |
| 22 Feb 2022 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 6,847 | 0.00 USD | deriv |
| 22 Feb 2022 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,882 | 0.00 USD | deriv |
| 19 Feb 2022 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,222 | 0.00 USD | |
| 19 Feb 2022 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 4,222 | 0.00 USD | deriv |
| 11 Aug 2021 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 12.98 USD | |
| 11 Aug 2021 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 19 Feb 2021 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 7,365 | 0.00 USD | deriv |
| 19 Feb 2021 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,222 | 0.00 USD | deriv |
| 21 Feb 2020 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,211 | 23.99 USD | |
| 21 Feb 2020 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 9,305 | 0.00 USD | deriv |
| 20 Jun 2019 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 10,000 | 9.13 USD | |
| 20 Jun 2019 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 25 Apr 2019 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 10,000 | 9.13 USD | |
| 25 Apr 2019 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 20 Aug 2018 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7,457 | 9.24 USD | |
| 20 Aug 2018 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 8,722 | 7.90 USD | |
| 20 Aug 2018 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 8,722 | 0.00 USD | deriv |